About FDA
SMG 1261.583
FDA STAFF MANUAL GUIDES, VOLUME I - ORGANIZATIONS AND FUNCTIONS
FOOD AND DRUG ADMINISTRATION
OFFICE OF MEDICAL PRODUCTS AND TOBACCO
CENTER FOR DRUG EVALUATION AND RESEARCH
OFFICE OF SURVEILLANCE AND EPIDEMIOLOGY
OFFICE OF PHARMACOVIGILANCE AND EPIDEMIOLOGY
DIVISION OF PHARMACOVIGILANCE I
Effective Date: 07/08/2011
1. DIVISION OF PHARMACOVIGILANCE I (DKKNOHC)
A. Provides leadership, direction, planning, budgeting, management and supervision of Division programs and staff
B. Reviews and analyses of adverse event reports from industry submissions and from reports submitted directly to Food and Drug Administration (FDA) related to marketed drugs in order to detect safety signals and evaluate risk; and performs follow-up when such signals are detected
C. Provides development and assessment of methodologies and best practices for scientifically sound safety signal detection and drug risk evaluation related to the postmarketing safety of drugs
D. Provides safety signal detection and drug risk evaluation support to medical review Divisions in areas of responsibility, as well as, for Advisory Committee presentations
E. Provides recommendations on safety signal detection and drug risk evaluation aspects of proposed and implemented Risk Minimization Action Plans (RiskMAPs) or Risk Management Plans (RMPs)
F. Provides input on signal detection and drug risk evaluation included in information for the public related to significant safety information regarding drugs, biologics, devices and foods
G. Develops and implements internal Manuals of Policies and Procedures (MAPPs) and guidance on safety signal detection and drug risk evaluation initiatives
2. AUTHORITY AND EFFECTIVE DATE
The functional statements for this Division were approved by the Secretary of the Department of Health and Human Services on July 8, 2011.
| STATUS (I, R, C) | DATE APPROVED | LOCATION OF CHANGE HISTORY | CONTACT | APPROVING OFFICIAL |
|---|---|---|---|---|
| Initial | 03/03/21010 | N/a | CDER/OM | Commissioner of Food and Drugs |
| Revision | 07/08/2011 | N/a | CDER/OM | Secretary of the Department of Health and Human Services |







